BR0318125A - Derivados de benzeno trìmeros macrociclicamente substituìdos - Google Patents

Derivados de benzeno trìmeros macrociclicamente substituìdos

Info

Publication number
BR0318125A
BR0318125A BR0318125-1A BR0318125A BR0318125A BR 0318125 A BR0318125 A BR 0318125A BR 0318125 A BR0318125 A BR 0318125A BR 0318125 A BR0318125 A BR 0318125A
Authority
BR
Brazil
Prior art keywords
macrocyclically
benzene derivatives
substituted
trimeric benzene
substituted trimeric
Prior art date
Application number
BR0318125-1A
Other languages
English (en)
Inventor
Johannes Platzek
Hanns-Joachim Weinmann
Heiko Schirmer
Jose Luis Martin
Juan R Harto
Bj Rn Riefke
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0318125A publication Critical patent/BR0318125A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"DERIVADOS DE BENZENO TRìMEROS MACROCICLICAMENTE SUBSTITUìDOS". A presente invenção refere-se a complexos metálicos de fórmula geral (I), na qual Hal representa bromo ou iodo e A¬ 1¬ e A¬ 2¬ têm diferentes significados, que são apropriados como agentes de contraste.
BR0318125-1A 2003-02-19 2003-12-12 Derivados de benzeno trìmeros macrociclicamente substituìdos BR0318125A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10307759A DE10307759B3 (de) 2003-02-19 2003-02-19 Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel
PCT/EP2003/014149 WO2004074267A1 (de) 2003-02-19 2003-12-12 Trimere makrocyclisch substituierte benzolderivate

Publications (1)

Publication Number Publication Date
BR0318125A true BR0318125A (pt) 2006-02-07

Family

ID=32891780

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0318125-1A BR0318125A (pt) 2003-02-19 2003-12-12 Derivados de benzeno trìmeros macrociclicamente substituìdos

Country Status (16)

Country Link
EP (1) EP1594851A1 (pt)
JP (1) JP2006514664A (pt)
KR (1) KR20050105474A (pt)
CN (1) CN1753878A (pt)
AR (1) AR043205A1 (pt)
AU (1) AU2003290032B2 (pt)
BR (1) BR0318125A (pt)
CA (1) CA2516467A1 (pt)
CR (1) CR7937A (pt)
DE (1) DE10307759B3 (pt)
EC (1) ECSP056026A (pt)
MX (1) MXPA05008781A (pt)
NO (1) NO20054291L (pt)
RU (1) RU2005128834A (pt)
WO (1) WO2004074267A1 (pt)
ZA (1) ZA200507437B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE102004023093B3 (de) * 2004-05-05 2006-03-02 Schering Ag Trimere makrocyclisch substituierte Halogen-Benzolderivate
DE102004026103A1 (de) * 2004-05-25 2005-12-22 Schering Ag Trimere makrocyclisch substituierte Aminoisophthalsäure-Halogen-Benzolderivate
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP6124078B2 (ja) * 2010-08-26 2017-05-10 ツイ，クンユァン 巨大環状脂肪族化合物及びその応用
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
CN104672259B (zh) * 2015-02-02 2017-04-05 湖北大学 一种含碘稀土铕(ⅲ)配合物及其制备方法和应用
CN104721844B (zh) * 2015-02-02 2017-11-03 湖北大学 一种新型ct，mri，稀土荧光三功能微球及其制备方法和应用
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN105254529B (zh) * 2015-09-21 2017-05-31 西南石油大学 一种树形席夫碱缓蚀剂的制备方法
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CN107445911B (zh) * 2017-06-19 2019-07-05 南京科技职业学院 一种二核含钆磁共振对比剂及其制备与应用
CA3120665A1 (en) 2018-11-23 2020-05-28 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
WO1994027644A1 (en) * 1993-06-02 1994-12-08 Bracco S.P.A. Iodinated paramagnetic chelates, and their use as contrast agents
FR2736051B3 (fr) * 1995-06-29 1997-09-26 Guerbet Sa Complexes metalliques de polyaminoacides, leur procede de preparation et leur utilisation en imagerie diagnostique
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale

Also Published As

Publication number Publication date
ECSP056026A (es) 2006-01-27
CN1753878A (zh) 2006-03-29
WO2004074267A1 (de) 2004-09-02
JP2006514664A (ja) 2006-05-11
CA2516467A1 (en) 2004-09-02
CR7937A (es) 2006-02-07
RU2005128834A (ru) 2006-03-20
AU2003290032B2 (en) 2009-04-23
NO20054291L (no) 2005-11-17
AU2003290032A1 (en) 2004-09-09
KR20050105474A (ko) 2005-11-04
NO20054291D0 (no) 2005-09-16
EP1594851A1 (de) 2005-11-16
MXPA05008781A (es) 2006-03-10
AR043205A1 (es) 2005-07-20
ZA200507437B (en) 2007-02-28
DE10307759B3 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
BR0318125A (pt) Derivados de benzeno trìmeros macrociclicamente substituìdos
BRPI0410995A (pt) derivados de n-alquinil-2-(arilóxi substituìdo)alquiltioamida como fungicidas
BRPI0408378A (pt) cetoenóis cìclicos substituìdos por 2,4,6-fenila
BR0313420A (pt) Quinolonas microbicidas, suas composições e usos
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ATE535527T1 (de) Verbindung mit affinität zu amyloid
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ATE534747T1 (de) 1l1rl-1 als marker für kardiovaskuläre erkrankungen
RS52505B (en) PHOSPHORAMIDATE ALKYLATER PRODUCTS
TW200612195A (en) Oxime derivatives and the use therof as latent acids
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
GT200200069A (es) Derivados de mercaptoacetilamida, procedimiento para su preparacion y su uso
UY29327A1 (es) Derivados de n-(heteroaril)- 1 h- indol-2-carboxamidas, su preparacion y su aplicacion en terapeutica
GT200300072AA (es) Aminoacidos con afinidad por la proteina alfa2delta (solicitud fraccionaria
ATE311367T1 (de) 5-substituierte alkylaminopyrazol-derivative als pestizide
MY148953A (en) Substituted biphenyl carboxylic acids and derivatives thereof
DE60217854D1 (de) Herstellung von agonisten und antagonisten von cholecystokinin und ihre therapeutische und diagnostische verwendung
DE69920923D1 (de) Anthranilsäurederivate
ATE493410T1 (de) Neue verbindung mit affinität zu amyloid
SE9901077D0 (sv) Novel use
DE50105075D1 (de) Oxidationsfärbemittel
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.